[EN] TRIAZINOINDOLE-BASED CHEMICAL INHIBITORS OF EUKARYOTIC RIBOSOME BIOGENESIS<br/>[FR] INHIBITEURS CHIMIQUES DE BIOGENÈSE DE RIBOSOMES EUCARYOTES À BASE DE TRIAZINOINDOLE
申请人:UNIV ROCKEFELLER
公开号:WO2018044986A1
公开(公告)日:2018-03-08
Triazinoindole-based chemical inhibitors of eukaryotic ribosome genesis are disclosed. The compounds have the following structure: The compounds disclosed are useful in treatment of fungal disease and similar diseases associated with the dysregulation of the midasin signaling pathway.
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure–Activity Relationship Study
作者:Sandeep Rana、Elizabeth C. Blowers、Calvin Tebbe、Jacob I. Contreras、Prakash Radhakrishnan、Smitha Kizhake、Tian Zhou、Rajkumar N. Rajule、Jamie L. Arnst、Adnan R. Munkarah、Ramandeep Rattan、Amarnath Natarajan
DOI:10.1021/acs.jmedchem.6b00400
日期:2016.5.26
Design, synthesis, and evaluation of α-methylene-γ-butyrolactone analogues and their evaluation as anticanceragents is described. SAR identified a spirocyclic analogue 19 that inhibited TNFα-induced NF-κB activity, cancer cell growth and tumor growth in an ovarian cancer model. A second iteration of synthesis and screening identified 29 which inhibited cancer cell growth with low-μM potency. Our data